{
    "Trade/Device Name(s)": [
        "Herpes Simplex Virus Type 1 IgG ELISA Test"
    ],
    "Submitter Information": "Gold Standard Diagnostics",
    "510(k) Number": "K131334",
    "Predicate Device Reference 510(k) Number(s)": [
        "K000238"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXJ"
    ],
    "Summary Letter Date": "February 28, 2014",
    "Summary Letter Received Date": "January 30, 2014",
    "Submission Date": "January 29, 2014",
    "Regulation Number(s)": [
        "21 CFR 866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes simplex virus serological assays"
    ],
    "Analyte Class(es)": [
        "serology",
        "virology"
    ],
    "Analyte(s)": [
        "IgG antibodies to Herpes Simplex Virus Type 1 (HSV-1)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Spectrophotometer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme linked immunosorbent assay (ELISA)"
    ],
    "Methodologies": [
        "Serological testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Control",
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Gold Standard Diagnostics Herpes Simplex Virus Type 1 IgG ELISA Test for qualitative detection of IgG antibodies to HSV-1 in human serum",
    "Indications for Use Summary": "Qualitative detection of IgG antibodies to Herpes Simplex Virus Type 1 (HSV-1) in human serum as an aid for presumptive diagnosis of HSV-1 infection in sexually active individuals and expectant mothers; not for blood/plasma donor screening or use in pediatric, neonatal, or immunocompromised patients.",
    "fda_folder": "Microbiology"
}